CDEK
← All organizations

Palatin Technologies

For profitContributed to NME

Also known as: Palatin | Palatin Technologies | PALATIN TECHNOLOGIES | Palatin Technologies, Inc | Palatin Technologies, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Feb 1, 2006

First marketed drug

Jul 2, 2004

First NDA

Jul 2, 2004

Last known activity

Aug 5, 2024

Timeline

1990s

  1. Jan 1, 1996

    Palatin Technologies— Founded

2000s

  1. Jul 2, 2004

    technetium (99m tc) fanolesomab— NDA Organization

2010s

  1. Jun 21, 2019

    bremelanotide— Marketing Organization

  2. Jun 21, 2019

    bremelanotide— NDA Secondary Org

Drugs by trial phase (6 distinct, 12 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (4 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (2)

Recent trials (21)

Details

Founded
Cranbury, NJ, US Jan 1, 1996
First NDA
Jul 2, 2004
Last known activity
Aug 5, 2024